Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2
Clinical trial NCT03338348 · COMPLETED
Trial details
- NCT number
- NCT03338348
- Sponsor
- University of Ulm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-19
- Primary completion
- 2019-10-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.